Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, Beomseok Suh, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Young Whan Kim, Dae Seog Heo
Korean J Intern Med. 2016;31(6):1140-1149.   Published online 2016 Mar 28     DOI: https://doi.org/10.3904/kjim.2015.062
Citations to this article as recorded by Crossref logo
Nutritional assessment and quality of life in patients with non-small cell lung cancer undergoing immunotherapy
Theocharis Konstantinidis, Chrysi Fragkioudaki, Evridiki Patelarou, Michail Zografakis-Sfakianakis, Symeon Naoum, Ioanna Tsatsou, Ioannis Kalemikerakis, Ourania Govina
International Journal of Palliative Nursing.2023; 29(3): 118.     CrossRef
Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence
Chuan-long Zhang, Meng-qi Gao, Xiao-chen Jiang, Xue Pan, Xi-yuan Zhang, Yi Li, Qian Shen, Yan Chen, Bo Pang
Annals of Medicine.2023; 55(1): 1294.     CrossRef
The real‐world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post‐ALTER0203 trial era
Ren‐Shu Zhang, Jie Liu, Yao‐Tiao Deng, Xin Wu, Yu Jiang
Cancer Medicine.2022; 11(11): 2271.     CrossRef
Switch to EGFR-TKI after upfront platinum doublet induction therapy in non-small cell lung cancer (NSCLC) patients with EGFR (Epidermal Growth Factor Receptor) mutation: A multicentre retrospective study
Susana Baptista de Almeida, Ana Sofia Spencer, Claudia Lares dos Santos, Gonçalo Fernandes, Pedro Simões, Sónia Silva, Tiago Dias Domingues, Marta Honório
Cancer Treatment and Research Communications.2022; 31: 100526.     CrossRef
Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer
Anning Xiong, Wei Nie, Lei Cheng, Hua Zhong, Tianqing Chu, Runbo Zhong, Jun Lu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Feng Pan, Baohui Han, Xueyan Zhang
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Predicting Outcomes in NSCLC: Staging or Biology or Both?
Cecilia L. Benz, Cornelius Dyke
Journal of Investigative Surgery.2021; 34(4): 441.     CrossRef
Expected and paradoxical effects of obesity on cancer treatment response
Marco Gallo, Valerio Adinolfi, Viola Barucca, Natalie Prinzi, Valerio Renzelli, Luigi Barrea, Paola Di Giacinto, Rosaria Maddalena Ruggeri, Franz Sesti, Emanuela Arvat, Roberto Baldelli, Emanuela Arvat, Annamaria Colao, Andrea Isidori, Andrea Lenzi, Rober
Reviews in Endocrine and Metabolic Disorders.2021; 22(4): 681.     CrossRef
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy
Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, Riccardo Bonacini, Raffaella Marcheselli, Linda Reverberi, Annarita Pecchi, Renata Menozzi, Pietro Torricelli, Federica Bertolini, Fausto Barbieri, Massimo Dominici
Clinical Nutrition ESPEN.2021; 43: 64.     CrossRef
Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
Yakup Bozkaya, Osman Köstek, Abdullah Sakin, Deniz Tataroğlu Özyükseler, Teoman Şakalar, İbrahim Çil
Supportive Care in Cancer.2020; 28(5): 2273.     CrossRef
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment
Norimitsu Kasahara, Hisao Imai, Ichiro Naruse, Yusuke Tsukagoshi, Mie Kotake, Noriaki Sunaga, Kyoichi Kaira, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada
Thoracic Cancer.2020; 11(8): 2188.     CrossRef
Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis
Jianqi Hao, Cong Chen, Fangfang Wan, Yuzhou Zhu, Hongyu Jin, Jian Zhou, Nan Chen, Jing Yang, Qiang Pu
Frontiers in Oncology.2020;[Epub]     CrossRef
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
Karam Khaddour, Sandra L. Gomez-Perez, Nikita Jain, Jyoti D. Patel, Yanis Boumber
Frontiers in Oncology.2020;[Epub]     CrossRef
Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment
Sami Antoun, Hugues Morel, Pierre‐Jean Souquet, Veerle Surmont, David Planchard, Franck Bonnetain, Pascal Foucher, Thomas Egenod, Ivan Krakowski, Hélène Gaudin, Didier Debieuvre
Journal of Cachexia, Sarcopenia and Muscle.2019; 10(4): 782.     CrossRef
Muscle derangement and alteration of the nutritional machinery in NSCLC
Ilaria Trestini, Anastasios Gkountakos, Luisa Carbognin, Alice Avancini, Massimo Lanza, Alessio Molfino, Simonetta Friso, Vincenzo Corbo, Giampaolo Tortora, Aldo Scarpa, Michele Milella, Emilio Bria, Sara Pilotto
Critical Reviews in Oncology/Hematology.2019; 141: 43.     CrossRef
Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis
J Wang, H Xu, S Zhou, D Wang, L Zhu, J Hou, J Tang, J Zhao, S Zhong
European Journal of Clinical Nutrition.2018; 72(1): 4.     CrossRef
Closing the Gap in Nutrition Care at Outpatient Cancer Centers: Ongoing Initiatives of the Oncology Nutrition Dietetic Practice Group
Elaine B. Trujillo, Suzanne W. Dixon, Katrina Claghorn, Rhone M. Levin, Jeannine B. Mills, Colleen K. Spees
Journal of the Academy of Nutrition and Dietetics.2018; 118(4): 749.     CrossRef
Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis
Zhongtao Wang, Yongjun Wang, Xinmei Zhang, Tingting Zhang
Clinica Chimica Acta.2018; 486: 303.     CrossRef
Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis
Yuanyuan Hu, Jie Shen, RuiKe Liu, ZhiMei Feng, ChangNing Zhang, Li Ling, LiBo Chen
The International Journal of Biological Markers.2018; 33(4): 372.     CrossRef
The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis
Yaqi Huang, Siqi Wei, Nan Jiang, Lijuan Zhang, Siyuan Wang, Xiaona Cao, Yue Zhao, Peiguo Wang
BMC Cancer.2018;[Epub]     CrossRef